Oncology Today with Dr Neil Love
En podkast av Research To Practice
348 Episoder
-
Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
Publisert: 20.5.2024 -
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
Publisert: 13.5.2024 -
Virtual Case Library: Metastatic Triple-Negative Breast Cancer
Publisert: 8.5.2024 -
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
Publisert: 6.5.2024 -
Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
Publisert: 3.5.2024 -
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
Publisert: 1.5.2024 -
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
Publisert: 26.4.2024 -
Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
Publisert: 24.4.2024 -
Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
Publisert: 23.4.2024 -
Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
Publisert: 15.4.2024 -
Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
Publisert: 12.4.2024 -
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
Publisert: 5.4.2024 -
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
Publisert: 5.4.2024 -
The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
Publisert: 3.4.2024 -
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
Publisert: 27.3.2024 -
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
Publisert: 26.3.2024 -
Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
Publisert: 25.3.2024 -
Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
Publisert: 21.3.2024 -
Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
Publisert: 19.3.2024 -
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
Publisert: 15.3.2024
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
